Home > Healthcare > Drug Device Combination > Therapeutic Systems > Demineralized Bone Matrix Market

Demineralized Bone Matrix Market Trends

Report ID: GMI8338
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Demineralized Bone Matrix Market Trends

Technological advancements in demineralized bone matrix play a significant role in orthopedic and dental fields. These advancements aim to improve bone healing, increase surgical precision, enhance biocompatibility, and promote better integration with host tissues, leading to improved patient outcomes and reduced complications.

Advancements in processing techniques have led to more efficient demineralization methods while preserving the structural integrity and bioactivity of the bone matrix.
Furthermore, emerging technologies such as healthcare 3D printing along with tissue engineering, enables the customization and personalization of DBM grafts. This customization aligns with the unique anatomical and biomechanical needs of patients, ultimately enhancing the precision of surgical outcomes.
Moreover, advancements in DBM technology allows for customized formulations tailored to specific clinical applications and patient needs. This includes variations in particle size, shape, and composition to optimize handling and integration with surrounding tissues.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Demineralized bone matrix market size was USD 832.8 million in 2023 and is expected to register 4.9% CAGR from 2024-2032 owing to the rising prevalence of orthopedic disorders emerging, as a significant public health concern worldwide.

The gel segment recorded USD 112.1 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to adhere to surrounding tissues and bone surfaces, thereby increasing the stability and longevity of the graft at site.

North America demineralized bone matrix industry reached USD 337.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a sophisticated healthcare infrastructure and rising prevalence of orthopedic conditions in the region.

Institut Straumann AG, Johnson & Johnson, Medtronic plc, RTI Surgical, Inc., Seaspine Holdings Corporation, Stryker Corporation, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc., are some of the major demineralized bone matrix companies worldwide.